IGF2BP1 and neoplasm: Except ovarian carcinoma-derived OVCAR cells, which expressed CDH1 and KRT8 but barely any of the analyzed mesenchymal markers, significant IGF2BP1 expression was only observed in mesenchymal-like tumor- or metastases-derived cells.